| 发明名称 |
CRYSTAL MODIFICATION OF 1-(2,6-DIFLUOROBENZYL)-1H-1,2,3-TRIAZOLE-4-CARBOXAMIDE AND ITS USE AS ANTIEPILEPTIC |
| 摘要 |
The invention relates to the novel modifications B and C of the compound 1 (2,6-difluorobenzyl)-1H-1,2,3-triazole-4-carboxamide of formula (I), its use for the treatment of epilepsy and pharmaceutical preparations comprising these crystal modifications.
|
| 申请公布号 |
CA2256015(A1) |
申请公布日期 |
1998.12.17 |
| 申请号 |
CA19982256015 |
申请日期 |
1998.06.08 |
| 申请人 |
NOVARTIS AG |
发明人 |
HOFMEIER, URS CHRISTOPH;BURKHARD, ANDREAS;SZELAGIEWICZ, MARTIN;SCHERRER, WALTER;PORTMANN, ROBERT |
| 分类号 |
A61K31/41;A61K31/4192;A61P25/08;C07D249/04;(IPC1-7):C07D249/04 |
主分类号 |
A61K31/41 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
